Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1989-3-23
|
pubmed:abstractText |
The present study shows that the distribution of T lymphocytes in gastrointestinal carcinomas and their metastases mimic the distribution of T lymphocytes in normal intestine. The composition of the peritumoral reaction resembled that of normal lamina propria with a predominance of CD3 + CD4 + T cells. In contrast, lymphocytes located between carcinomatous cells showed phenotypical features similar to those of intraepithelial lymphocytes (IEL) in normal intestine; in particu(abstractlar they expressed the antigen defined by HML-1, a monoclonal antibody raised against normal human intestinal IEL which reveals 95% IEL but very few cells in lymphoid (abstractorgans and blood. As normal intestinal IEL, the majority of intratumoral lymphocytes had the CD3+ CD8+ phenotype. A panel of monoclonal antibodies and double immunostaining techniques permitted a better characterisation of minor subsets of IEL. Two subsets of HML1 + CD3 + CD4- CD8- and of HML1+ CD3- cells, representing 2% and 3% of normal intestinal IEL respectively, did not significantly increase in carcinomatous epithelium. In contrast, in carcinomatous epithelium, but not in normal intestinal epithelium, we observed the appearance of a few lymphocytes displaying the phenotype of activated T cells (CD25+) or of natural killer cells (NKHI+) or of suppressor cells (CD11+). Such cells may participate in antitumoral defence. Although a similar population of HML1+ lymphocytes is associated with normal and carcinomatous intestinal epithelium, some interactions between lymphocytes and epithelial cells may not be maintained in tumoral epithelium. It has previously been shown that HLA-DR expression by enterocytes is modulated by intraepithelial lymphocytes. In our study, no correlation could be shown between the degree of lymphocytic infiltration and the expression of HLA-DR antigens on carcinomatous cells.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-2425030,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-2873198,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3102967,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3105871,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-31410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3305585,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3362141,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-338444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3486193,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3491776,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3498635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3525341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-3871194,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-6425398,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-6687894,
http://linkedlifedata.com/resource/pubmed/commentcorrection/3265403-77279
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0017-5749
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1632-8
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:3265403-Adenocarcinoma,
pubmed-meshheading:3265403-Antibodies, Monoclonal,
pubmed-meshheading:3265403-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:3265403-Epithelium,
pubmed-meshheading:3265403-Gastrointestinal Neoplasms,
pubmed-meshheading:3265403-Humans,
pubmed-meshheading:3265403-Liver Neoplasms,
pubmed-meshheading:3265403-T-Lymphocytes
|
pubmed:year |
1988
|
pubmed:articleTitle |
Same peculiar subset of HML1 + lymphocytes present within normal intestinal epithelium is associated with tumoral epithelium of gastrointestinal carcinomas.
|
pubmed:affiliation |
INSERM U239, Faculté de Médecine Xavier Bichat, Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|